Vijaya Diagnostic Centre Limited
VIJAYA · General/Diversified · NSE
₹1,018
Current Market Price
Fair Value (DCF)
₹417
Margin of Safety
-59.0%
Updated 1d ago
YieldIQ Score
43/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
45%
ROE
17.9%
Debt/Equity
0.00
WACC
9.8%
Market Cap
₹0.10 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
19.6%
Return on capital employed
EV / EBITDA
33.7×
Enterprise multiple
Debt / EBITDA
1.0×
Leverage vs earnings
Interest Coverage
8.9×
EBIT covers interest
Current Ratio
1.89×
Short-term liquidity
Asset Turnover
0.58×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,018.4
Bear case
₹236.03
MoS -331.5%
Base case
₹417.26
MoS -144.1%
Bull case
₹572.63
MoS -77.8%
Ratio Trends
VIJAYA · last 4 annual periods
ROE
17.9%
ROCE
25.8%
Operating Margin
—
Debt / Equity
0.40×
PE
145.2×
EV / EBITDA
20.6×
Historical Financials
VIJAYA · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹462 Cr | ₹121 Cr | ₹155 Cr | ₹681 Cr | +13.8% |
| EBITDA | ₹215 Cr | ₹195 Cr | ₹238 Cr | ₹288 Cr | +10.2% |
| EBIT | ₹164 Cr | ₹42.3 Cr | ₹50.1 Cr | — | -32.6% |
| PAT | ₹111 Cr | ₹27.7 Cr | ₹33.7 Cr | ₹143 Cr | +8.9% |
| EPS (diluted) | ₹10.69 | ₹2.68 | ₹3.26 | — | -32.7% |
| CFO | ₹158 Cr | ₹165 Cr | ₹183 Cr | ₹224 Cr | +12.4% |
| CapEx | — | — | — | ₹-95.6 Cr | — |
| FCF | — | — | — | ₹129 Cr | +0.0% |
| Total Assets | ₹713 Cr | ₹853 Cr | ₹983 Cr | ₹1274 Cr | +21.3% |
| Total Debt | — | ₹0.0 Cr | ₹0.0 Cr | ₹320 Cr | — |
| Shareholders' Equity | — | ₹545 Cr | ₹657 Cr | ₹799 Cr | +13.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
VIJAYA vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| METROPOLIS METROPOLIS | — | — | Pending | 10.9% | — |
| THYROCARE THYROCARE | — | — | Pending | 16.7% | — |
| SYNGENE Syngene International Limited | -41.7% | 43 | Overvalued | 10.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for VIJAYA in the last 10 years.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of VIJAYA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for VIJAYA →
Compare
Head-to-head with peers
Compare VIJAYA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse VIJAYANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.